Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation (Q42799566)

7 November 2017

Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation (English)

1 reference

7 November 2017

1 reference

Pan Hu

1

1 reference

PubMed ID

25030245

7 November 2017

Ling Zhao

series ordinal

2

1 reference

PubMed ID

25030245

7 November 2017

Jiangang Chen

series ordinal

3

1 reference

7 November 2017

17 July 2014

1 reference

European Journal of Nutrition

7 November 2017

1 reference

7 November 2017

54

1 reference

7 November 2017

4

1 reference

7 November 2017

569-579

1 reference

https://scigraph.springernature.com/pub.10.1007/s00394-014-0738-4

7 November 2017

0 references

cites work

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Changes in white adipose tissue metabolism induced by resveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol enhances fatty acid oxidation capacity and reduces resistin and Retinol-Binding Protein 4 expression in white adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol inhibits the protein expression of transcription factors related adipocyte differentiation and the activity of matrix metalloproteinase in mouse fibroblast 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

An adipocentric perspective of resveratrol as a calorie restriction mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

The fat controller: adipocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Effects of parabens on adipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

The effects of NOD activation on adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Human corticosteroid binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Transcriptional control of adipocyte formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-014-0738-4

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes

1 reference

12 December 2020

Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK.

1 reference

12 December 2020

Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice

1 reference

12 December 2020

The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men.

1 reference

12 December 2020

Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term caloric restriction

1 reference

12 December 2020

Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum

1 reference

12 December 2020

Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARγ activation

1 reference

12 December 2020

AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins

1 reference

12 December 2020

10.1007/S00394-014-0738-4

Identifiers

DOI

1 reference

7 November 2017

1 reference

PubMed ID

25030245